Literature DB >> 2874423

The spectrum of hepatotoxicity due to drugs.

S Sherlock.   

Abstract

Drugs in common use can cause toxic effects on the liver which can mimic almost every naturally occurring liver disease in man. Drugs can have direct (metabolite-related) toxic effects; they can also cause deposition of microvesicular fat in hepatocytes; or they can provoke reactions resembling acute alcoholic hepatitis (phospholipidosis) or acute viral hepatitis. Hepatotoxicity can also be part of a general hypersensitivity reaction, or hepatic fibrosis or cholestasis can predominate. Drugs can lead to almost any type of vascular disease in the liver and to benign and malignant tumours.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2874423     DOI: 10.1016/s0140-6736(86)92144-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  13 in total

1.  Glipizide treatment with short-term alcohol abuse resulting in subfulminant hepatic failure.

Authors:  Marius John-Marc Ilario; Hach Vladimir Turyan; Constantine A Axiotis
Journal:  Virchows Arch       Date:  2003-04-26       Impact factor: 4.064

Review 2.  Idiosyncratic drug reactions: a mechanistic evaluation of risk factors.

Authors:  B K Park; M Pirmohamed; N R Kitteringham
Journal:  Br J Clin Pharmacol       Date:  1992-11       Impact factor: 4.335

3.  Granular cells as a marker of early amiodarone hepatotoxicity: a pathological and analytical study.

Authors:  N A Shepherd; A M Dawson; P R Crocker; D A Levison
Journal:  J Clin Pathol       Date:  1987-04       Impact factor: 3.411

Review 4.  Rare and serious adverse reactions.

Authors:  G R Venning
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Jul-Aug

5.  Recovery from diclofenac-induced hypersensitive fulminant hepatitis and prostaglandins.

Authors:  M Ohana; K Hajiro; H Takakuwa; K Okazaki
Journal:  Dig Dis Sci       Date:  1997-10       Impact factor: 3.199

6.  Liver damage associated with minocycline use in acne: a systematic review of the published literature and pharmacovigilance data.

Authors:  R A Lawrenson; H E Seaman; A Sundström; T J Williams; R D Farmer
Journal:  Drug Saf       Date:  2000-10       Impact factor: 5.606

Review 7.  Drug-induced immunotoxicity.

Authors:  P M Dansette; E Bonierbale; C Minoletti; P H Beaune; D Pessayre; D Mansuy
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1998 Oct-Dec       Impact factor: 2.441

8.  Fulminant hepatic failure in a child as a potential adverse effect of trimethoprim-sulphamethoxazole.

Authors:  B Simma; B Meister; J Deutsch; W Sperl; F Fend; D Ofner; R Margreiter; W Vogel
Journal:  Eur J Pediatr       Date:  1995-07       Impact factor: 3.183

9.  Evidence for prostaglandin-producing suppressor cells in drug-induced liver injury and implications in the diagnosis of drug sensitization.

Authors:  R M Victorino; V A Maria; L A Pinto
Journal:  Clin Exp Immunol       Date:  1992-01       Impact factor: 4.330

Review 10.  Pharmacokinetics of common analgesics, anti-inflammatories and antipyretics in children.

Authors:  P D Walson; M E Mortensen
Journal:  Clin Pharmacokinet       Date:  1989       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.